News and blogs
414 results found.
Survey highlights forgotten pandemic victims
As the country as a whole returns to normal, a quarter of people with blood cancer remain anxious about leaving their home
People affected by blood cancer help decide what research we fund
For the first time at Blood Cancer UK, this year a group of 16 people affected by blood cancer reviewed all applications received by us for research funding.
Blood Cancer UK's partnerships strategy
Discover how Blood Cancer UK is refreshing its partnerships strategy to account for the changing landscape since the COVID-19 pandemic.
Blood Cancer UK's community outreach strategy
Read about Blood Cancer UK's strategy to reach and support more people with blood cancer.
Meet some of our incredible volunteers
Our volunteer co-ordinator introduces some of the incredible volunteers she's met in the role.
Evusheld – is it effective?
In this blog, we talk about what the latest research is telling us about how effective Evusheld is.
Blood Cancer UK's research strategy
Since Blood Cancer UK was formed in 1960, it has invested over £500m in lifesaving blood cancer research.
This is Blood Cancer
Saturday 28 May is World Blood Cancer Day and we’re delighted to be able to share this new, hour-long documentary including films from Blood Cancer UK and other partners.
Our position on Evusheld
Since Evusheld was approved for use by MHRA, we’ve heard from the blood cancer community that one of their greatest concerns is the delay in its rollout across the UK. We wanted to address this directly and explain the work we’ve been doing.
One in 22 Covid deaths are in people with blood cancer
According to new data from the Office of National Statistics, 1 in every 22 people who died of Covid in England and Wales between January and March had blood cancer.
Blood Cancer UK's strategy
Read Blood Cancer UK's update on our organisational strategy.
We're funding 13 new research projects
Find out more about the latest blood cancer research projects that will receive £3 million pounds of funding from Blood Cancer UK
Our audiences: who should we be talking to?
As part of Blood Cancer UK's new organisational strategy, we looked at how we can define and develop our audiences so we can work towards our vision of beating blood cancer.
What happens if I have blood cancer and test positive for covid?
We talked to six people with blood cancer about their experience of accessing new antiviral and antibody treatments after they tested positive for covid.
COVID-19 booster jabs and blood cancer
New data reveals just 45% of immunocompromised people in England have had a booster dose of the Covid vaccine.
I can’t be a cancer patient. I am a mother!
Emily was diagnosed with blood cancer when her daughter was just 18 months old. Here, she reflects on the emotional impact of facing cancer as a mother. Eight years on, Emily is 'officially cured' and is enjoying precious time with her daughter.
Find out more about the Covid antibody treatment Evusheld
The treatment consists of two long-acting antibodies called tixagevumab and cilgavimab.
What do we mean when we talk about beating blood cancer?
Our Chief Executive, Gemma Peters, is writing to update you on our organisational strategy. With the help of our community, we first looked at what we mean by beating blood cancer, and came up with an initial draft of a vision statement.
Our response to Evusheld – a treatment to prevent Covid for the immunosuppressed
While we welcome the news of a new Covid treatment for immunosuppressed people – called Evusheld – we call for the Government to urgently set out its approach on how it will use preventative treatments for them.
Why are people with blood cancer invited for a 5th vaccine dose (second booster)?
People with blood cancer are now being offered a second covid vaccine booster (a 5th vaccine dose). Here's why.
